Pharmaceutical

Bristol-Myers Squibb

$66.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.20 (+0.30%) Today
+$0.25 (+0.37%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BMY and other stocks, options, and ETFs commission-free!

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. The listed name for BMY is Bristol-Myers Squibb Co.

CEO
Giovanni Caforio
Employees
30,000
Headquarters
New York, New York
Founded
1933
Market Cap
146.71B
Price-Earnings Ratio
—
Dividend Yield
2.77
Average Volume
13.41M
High Today
$67.16
Low Today
$66.33
Open Price
$66.92
Volume
10.85M
52 Week High
$68.34
52 Week Low
$45.76

Collections

BMY News

BenzingaJan 15

Bristol-Myers Squibb's Debt Overview

Over the past three months, shares of Bristol-Myers Squibb (NYSE: BMY) moved higher by 8.86%. Before having a look at the importance of debt, let us look at how

BMY Earnings

$0.00
$0.57
$1.15
$1.72
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Feb 4, Pre-Market

You May Also Like

GTHX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure